The Lancet — AVİD

Ana Sayfa / Dergiler / Detay

SJR Q1 journal 2024 verisi

The Lancet

United Kingdom · Western Europe SJR 12,113 H-Index 936 Rank #59

7 kurum yayını (2011 – 2022) 4 akademisyen 3 × Q1+Q2 2 Scopus'ta

Kategoriler ve SJR Quartile (son yıl: 2024)

Kategori Adı	Quartile
Medicine (miscellaneous)	Q1

Kategori Quartile Tarihçesi (2010–2024)

Kategori	2024	2023	2022	2021	2020	2019	2017	2016	2015	2014	2013	2012	2011	2010
Medicine (miscellaneous)	Q1	Q1	Q1	Q1	Q1	Q1	Q1	Q1	Q1	Q1	Q1	Q1	Q1	Q1

Kurum Akademisyenlerinin Yayınları (7)

Dergi Listesine Dön

Tümü 2022 (2) 2021 (1) 2018 (2) 2015 (1) 2011 (1)

Scopus JCR Q1 SCI-Expanded 2022

Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-in…

PROFESÖR BANU TURĞUT ÖZTÜRK 279 Scopus atıf DOI Detay

Scopus JCR Q1 SCI-Expanded 2022

Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, ph…

PROFESÖR BANU TURĞUT ÖZTÜRK 216 Scopus atıf DOI Detay

JCR Q1 SCI-Expanded 2021

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) - (Ayşa Hacıoğlu bu yayında yazar değil katkıd…

PROFESÖR ABDULLAH TUNÇEZ DOI Detay

SCI 2018

Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial

DOÇENT AHMET HAKAN EKMEKCİ DOI Detay

SCI 2018

Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial.

PROFESÖR ŞEREFNUR ÖZTÜRK Detay

SCI 2015

Efficacy of nitric oxide with or without continuing antihypertensive treatment for management of high blood pressure in acute stroke ENOS a partial factorial randomised controlled trial

PROFESÖR ŞEREFNUR ÖZTÜRK DOI Detay

SCI 2011

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial

PROFESÖR ŞEREFNUR ÖZTÜRK DOI Detay

Kurum Yayın Özeti

09.04.26

Toplam
Yayın

Akademis-
yen

Scopus
Eşleşme

2011 – 2022 yılları arasında

Hızlı Erişim

Scimago'da Görüntüle Dergi Listesine Dön

Metrikler (2024)

Best
Quartile

12,113

SJR

936

H-Index

#59

Rank

12,12

Atıf/Yayın
(2y)

16,6

Ref/Yayın

3.963

Yayın
(3 Yıl)

55.580

Atıf
(3 Yıl)

25.187

Toplam
Kaynak

%43,4

Kadın
Yazar

SDG 455

Dergi Bilgileri

Yayıncı Elsevier B.V.

Ülke / Bölge United Kingdom · Western Europe

Tür journal

ISSN 01406736 · 01406736 · 01406736 · 01406736 · 01406736 · 01406736 · 01406736 · 01406736 · 01406736 · 01406736 · 01406736 · 01406736 · 01406736 · 01406736 · 1474547X · 1474547X · 1474547X · 1474547X · 1474547X · 1474547X · 1474547X · 1474547X · 1474547X · 1474547X · 1474547X · 1474547X · 1474547X · 1474547X

Scimago ID 16590

Yayın Kapsam Aralıkları

1823-2025 1823-2025 1823-2025 1823-2025 1823-2025 1823-2025 1823-2025 1823-2025 1823-2025 1823-2025 1823-2025 1823-2025 1823-2025 1823-2025

Geniş Alanlar

Medicine

SJR Trendi (2010–2024)

2010 2011 2012 2013 2014 2015 2016 2017 2019 2020 2021 2022 2023 2024

H-Index Trendi

936 2010 936 2011 936 2012 936 2013 936 2014 936 2015 936 2016 936 2017 936 2019 936 2020 936 2021 936 2022 936 2023 936 2024